Anna Argo is responsible for key account management, identification of collaborators, contract negotiations, investor relations, brand development, and more. Ms. Argo spent 10 years in non-profit development, most recently at Children’s Minnesota.

Sam Casey is Director, Program and Portfolio Management at Ponte Biosciences. He brings nearly 10 years of experience in biotech, entrepreneurship, and operations. He previously co-founded a dendritic cell therapy company and led the advanced technology team at a Johnson & Johnson biopharmaceutical manufacturing facility. He completed his MBA at Harvard Business School and studied Chemical Engineering at Michigan Tech.

Benazir Kerezoudis is the Director of Quality Assurance and Quality Systems at Ponte Biosciences, where she oversees the regulatory needs of the company through quality assurance systems and management. She leads all aspects of Quality Assurance, including developing, implementing, and maintaining quality systems to ensure compliance with recognized regulations and guidelines. Benazir establishes quality plans and policies, reports compliance activities to Executive leaders, and maintains QA and compliance programs and infrastructure. She performs internal and external audits, ensures effectiveness in a GxP international regulatory environment, and serves as an in-house advisor on GxP compliance. 

Ryan Schulze is a cell biologist with 20 years of experience in biochemical techniques. Dr. Schulze received his Ph.D. from the University of Kansas Medical Center and was most recently an Assistant Professor at the Mayo Clinic, studying the cell biology of hepatocytes in fatty liver disease.

John R. Swart, Ph.D. previously served as President and CEO of Exemplar Genetics. Dr. Swart has over 25 years of experience in the biomedical research industry with a focus on business development and operations management.